Abstract 313: Type II interleukin 1 receptor-modulated SETBP-1/SET/PP2A/p-ERK signaling reduces the therapeutic activity of regorafenib against human colorectal cancer cells

Author(s):  
Ai-Chung Mar ◽  
Chun-Ho Chu ◽  
Shung-Haur Yang ◽  
Jeng-Kai Jiang ◽  
Chung-Wai Shiau ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document